"Tens of thousands of HIV patients could soon to be offered a monthly pill to control the virus and keep the virus at bay. Results from a landmark trial show the drug was as effective as the daily cocktail of pills patients currently take. Experts claim the new pill, known as a nucleoside reverse transcriptase translocation inhibitor (NRTTI), could fulfill an 'unmet need' and replace the daily pills, improving compliance."
"Developed by pharmaceutical giant Merck, it has been tested on animals and humans, with further studies currently being undertaken in the hope of preventing HIV in those at low risk of infection. Charities estimate nearly 41 million adults and children across the world have HIV, including at least 113,000 in the UK. According to the World Health Organization (WHO), it ranks alongside tuberculosis as the world's most deadly infectious disease."
Tens of thousands of HIV patients may be offered a monthly pill to control the virus. A landmark trial showed the drug was as effective as the daily cocktail patients currently take. The nucleoside reverse transcriptase translocation inhibitor (NRTTI) could fulfill an 'unmet need' and replace daily pills, improving adherence. Developed by Merck, the drug has been tested on animals and humans, with further studies aiming to prevent HIV in people at low risk. Nearly 41 million people worldwide have HIV; WHO ranks it alongside tuberculosis as one of the most deadly infectious diseases. The pill inhibits replication by blocking a key step in DNA mutation.
Read at Mail Online
Unable to calculate read time
Collection
[
|
...
]